Back to
Capitolis Liquid Global Markets LLC
SYRE2 quarters
Position history for
Capitolis Liquid Global Markets LLC's holdings in Spyre Therapeutics, Inc
Capitolis Liquid Global Markets LLC previously held 0 shares of SYRE (Spyre Therapeutics, Inc), worth $0 as of 2025-Q3.
Final Value
$0
Final Shares
0
Total Value Change
-$2.7M
Total Shares Change
-183,000
Quarter-by-Quarter History
Other major holders of SYRE: FMR LLC, BlackRock, Inc., RTW INVESTMENTS, LP